Search

Your search keyword '"Magdalena, Kostkiewicz"' showing total 210 results

Search Constraints

Start Over You searched for: Author "Magdalena, Kostkiewicz" Remove constraint Author: "Magdalena, Kostkiewicz"
210 results on '"Magdalena, Kostkiewicz"'

Search Results

1. Multi-modality imaging in the CIRCULATE-AMI pilot study cohort: a framework for an imaging-based randomized controlled trial of Wharton jelly mesenchymal stem cell use to stimulate myocardial repair/regeneration

2. Objective, observer-independent evaluation of myocardial perfusion and function: the role of SPECT

3. Single-photon emission computed tomography as a fundamental tool in evaluation of myocardial reparation and regeneration therapies

4. Acute myocardial infarction reparation/regeneration strategy using Wharton’s jelly multipotent stem cells as an ‘unlimited’ therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial

5. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

6. Advances in Molecular Imaging in Infective Endocarditis

7. Genotoxicity Associated with 131I and 99mTc Exposure in Nuclear Medicine Staff: A Physical and Biological Monitoring Study

8. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre

9. The scintigraphic diagnosis of cardiac amyloidosis. An expert opinion endorsed by the Section of Nuclear Medicine of the Polish Cardiac Society and the Polish Nuclear Medicine Society

10. To what extent does prior antimicrobial therapy affect the diagnostic performance of radiolabeled leukocyte scintigraphy in infective endocarditis?

12. Cardiac rehabilitation: a good measure to improve quality of life in peri- and postmenopausal women with microvascular angina

13. Prostate cancer in patients from rural and suburban areas – PSA value, Gleason score and presence of metastases in bone scan

14. International Impact of COVID-19 on the Diagnosis of Heart Disease

15. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

16. Genotoxicity Associated with

17. Reduction in radioactive internal contamination by

18. The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy

19. Reduction in radioactive internal contamination by 99mTc among medical personnel in nuclear medicine facilities with the use of respiratory tract protection measures

20. Updates for the diagnosis and management of cardiac amyloidosis

21. Relationship between left ventricular global longitudinal strain, infarct size and left ventricular function in patients with acute myocardial infarction in a stem cell therapy study

22. Prevalence of cardiac amyloidosis in patients with unexplained left ventricle hypertrophy

23. The Diagnostic Value of 99mTc-HMPAO-Labelled White Blood Cell Scintigraphy and 18F-FDG PET/CT in Cardiac Device-Related Infective Endocarditis—A Systematic Review

24. Diagnostyka choroby niedokrwiennej serca za pomocą scyntygrafii perfuzyjnej z użyciem izotopu 99mTc-MIBI u pacjentów chorujących lub diagnozowanych w kierunku stabilnej choroby wieńcowej

25. Czynniki warunkujące jakość życia po implantacji kardiostymulatora

26. Scintigraphic and echocardiographic evaluation of patients with cardiac transthyretin amyloidosis and first-degree relatives

27. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

28. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

29. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

30. Evolution of left ventricular function after Wharton's jelly mesenchymal stem cells transcoronary administration: 5-year follow up in a pilot cohort of CIRCULATE-AMI Randomized Trial

31. Relationships between Pulmonary Hypertension Risk, Clinical Profiles, and Outcomes in Dilated Cardiomyopathy

33. Atypical course of an infective endocarditis in a patient with complex congenital heart disease, chronic hepatitis B and splenic marginal zone lymphoma

34. First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases

35. Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial

36. Indications for transvenous lead extraction and its procedural and early outcomes in elderly patients: a single-center experience

37. Indications, procedural and early results of transvenous lead extraction in elderly patients: single-centre experience

38. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis

39. The Prognostic Value of 99 mTc-HMPAO-Labeled Leucocyte SPECT/CT in Cardiac Device-Related Infective Endocarditis

40. P967 Profile of arrhythmia in pregnant women with different WHO class is similar

41. Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle

42. The role of 99mTc-HMPAO-labelled white blood cell scintigraphy in the diagnosis of cardiac device-related infective endocarditis

43. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis

44. The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy

45. The Prognostic Value of

46. P3362Added value of radiolabeled leukocyte scintigraphy to cardiac device-related infective endocarditis diagnostic criteria

47. P1471Multimodality imaging of left ventricular function and volumes in patients with acute and chronic myocardial injury - Novel insights

48. P4604Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)

49. Effects of Transendocardial Delivery of Bone Marrow–Derived CD133 + Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina

50. Angiotensin receptor neprilysin inhibitor treatment is safe and potentially efficacious in end‑stage hypertrophic cardiomyopathy

Catalog

Books, media, physical & digital resources